Annual D&A
$2.22 M
-$1.81 M-44.96%
December 31, 2023
Summary
- As of February 10, 2025, NGM annual depreciation & amortization is $2.22 million, with the most recent change of -$1.81 million (-44.96%) on December 31, 2023.
- During the last 3 years, NGM annual D&A has fallen by -$4.33 million (-66.12%).
Performance
NGM Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
Quarterly D&A
$518.00 K
-$17.00 K-3.18%
December 31, 2023
Summary
- As of February 10, 2025, NGM quarterly depreciation & amortization is $518.00 thousand, with the most recent change of -$17.00 thousand (-3.18%) on December 31, 2023.
- Over the past year, NGM quarterly D&A has dropped by -$91.00 thousand (-14.94%).
Performance
NGM Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM D&A
$2.22 M
-$96.00 K-4.14%
December 31, 2023
Summary
- As of February 10, 2025, NGM TTM depreciation & amortization is $2.22 million, with the most recent change of -$96.00 thousand (-4.14%) on December 31, 2023.
- Over the past year, NGM TTM D&A has dropped by -$996.00 thousand (-30.96%).
Performance
NGM TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
NGM Depreciation And Amortization Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -45.0% | -14.9% | -31.0% |
| 3 y3 years | -66.1% | -66.7% | -66.1% |
| 5 y5 years | -69.3% | -72.6% | -70.8% |
NGM Depreciation And Amortization Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -63.5% | at low | -65.0% | at low | -63.5% | at low |
| 5 y | 5-year | -70.8% | at low | -70.7% | at low | -70.8% | at low |
| alltime | all time | -70.8% | at low | -73.6% | at low | -71.3% | -21.5% |
NGM Biopharmaceuticals Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $2.22 M(-45.0%) | $518.00 K(-3.2%) | $2.22 M(-4.1%) |
| Sep 2023 | - | $535.00 K(-4.3%) | $2.32 M(-2.6%) |
| Jun 2023 | - | $559.00 K(-8.2%) | $2.38 M(-26.0%) |
| Mar 2023 | - | $609.00 K(-0.8%) | $3.22 M(-20.3%) |
| Dec 2022 | $4.04 M(-33.7%) | $614.00 K(+2.7%) | $4.04 M(-17.7%) |
| Sep 2022 | - | $598.00 K(-57.2%) | $4.90 M(-15.4%) |
| Jun 2022 | - | $1.40 M(-2.2%) | $5.79 M(-2.8%) |
| Mar 2022 | - | $1.43 M(-3.5%) | $5.96 M(-2.1%) |
| Dec 2021 | $6.09 M(-7.1%) | $1.48 M(-0.9%) | $6.09 M(-1.2%) |
| Sep 2021 | - | $1.49 M(-4.6%) | $6.16 M(-2.1%) |
| Jun 2021 | - | $1.56 M(+0.6%) | $6.29 M(-1.3%) |
| Mar 2021 | - | $1.55 M(+0.1%) | $6.38 M(-2.7%) |
| Dec 2020 | $6.55 M | $1.55 M(-4.2%) | $6.55 M(-3.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $1.62 M(-1.8%) | $6.77 M(-4.5%) |
| Jun 2020 | - | $1.65 M(-4.7%) | $7.09 M(-3.9%) |
| Mar 2020 | - | $1.73 M(-2.0%) | $7.38 M(-3.0%) |
| Dec 2019 | $7.61 M(+5.3%) | $1.77 M(-9.0%) | $7.61 M(-1.6%) |
| Sep 2019 | - | $1.94 M(+0.4%) | $7.73 M(+0.8%) |
| Jun 2019 | - | $1.94 M(-1.3%) | $7.67 M(+3.0%) |
| Mar 2019 | - | $1.96 M(+3.7%) | $7.44 M(+3.0%) |
| Dec 2018 | $7.22 M(+12.1%) | $1.89 M(+0.6%) | $7.22 M(+35.5%) |
| Sep 2018 | - | $1.88 M(+9.9%) | $5.33 M(+54.4%) |
| Jun 2018 | - | $1.71 M(-1.9%) | $3.45 M(+98.1%) |
| Mar 2018 | - | $1.74 M | $1.74 M |
| Dec 2017 | $6.44 M(+82.3%) | - | - |
| Dec 2016 | $3.53 M | - | - |
FAQ
- What is NGM Biopharmaceuticals annual depreciation & amortization?
- What is the all time high annual D&A for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals annual D&A year-on-year change?
- What is NGM Biopharmaceuticals quarterly depreciation & amortization?
- What is the all time high quarterly D&A for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals quarterly D&A year-on-year change?
- What is NGM Biopharmaceuticals TTM depreciation & amortization?
- What is the all time high TTM D&A for NGM Biopharmaceuticals?
- What is NGM Biopharmaceuticals TTM D&A year-on-year change?
What is NGM Biopharmaceuticals annual depreciation & amortization?
The current annual D&A of NGM is $2.22 M
What is the all time high annual D&A for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high annual depreciation & amortization is $7.61 M
What is NGM Biopharmaceuticals annual D&A year-on-year change?
Over the past year, NGM annual depreciation & amortization has changed by -$1.81 M (-44.96%)
What is NGM Biopharmaceuticals quarterly depreciation & amortization?
The current quarterly D&A of NGM is $518.00 K
What is the all time high quarterly D&A for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high quarterly depreciation & amortization is $1.96 M
What is NGM Biopharmaceuticals quarterly D&A year-on-year change?
Over the past year, NGM quarterly depreciation & amortization has changed by -$91.00 K (-14.94%)
What is NGM Biopharmaceuticals TTM depreciation & amortization?
The current TTM D&A of NGM is $2.22 M
What is the all time high TTM D&A for NGM Biopharmaceuticals?
NGM Biopharmaceuticals all-time high TTM depreciation & amortization is $7.73 M
What is NGM Biopharmaceuticals TTM D&A year-on-year change?
Over the past year, NGM TTM depreciation & amortization has changed by -$996.00 K (-30.96%)